MINI FUTURE LONG - IPSEN | Market Closed - Euronext Paris 12:30:01 2024-05-17 EDT | ||
| 1.1 EUR | -2.65% |
|
| Current month | +41.94% | ||
| 1 month | +171.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 1.1 | -2.65% |
| 24-05-16 | 1.13 | +1.80% |
| 24-05-15 | 1.11 | -1.77% |
| 24-05-14 | 1.13 | +12.44% |
| 24-05-13 | 1.005 | -4.74% |
Real-time Euronext Paris
Last update May 17, 2024 at 12:30 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
BNP Paribas
|
| 0PAOB | |
| ISIN | FRBNPP06LAY5 |
| Date issued | 2024-03-14 |
| Strike | 99.8 € |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 0.49 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.16 € |
|---|---|
| Lowest since issue | 0.275 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.8
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.58%
- Stock Market
- Certificates
- 0PAOB Certificat
